ANTI-XA ASSAYS FOR UNFRACTIONATED HEPARIN (UFH) AND LOW MOLECULAR WEIGHT HEPARIN (LMWH): ANALYSIS OF THE QUALITY OF PERFORMANCE BY NORTH AMERICAN LABORATORIES

被引：0
|
作者：
Black, Lesley [1 ]
Selby, Rita [1 ,2 ]
Hoffman, Suzanne [3 ]
Chen, Dong [4 ]
Meijer, Piet [5 ]
Plumhoff, Elizabeth [4 ]
Van Cott, Elizabeth [6 ]
机构：
[1] Univ Toronto, Lab Med Program, Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Clin Pathol, Toronto, ON, Canada
[3] Univ Wisconsin, Madison, WI USA
[4] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[5] ECAT Fdn, Voorschoten, Netherlands
[6] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2014年 / 89卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
124
引用
收藏
页码：E60 / E60
页数：1
相关论文
共 50 条
  • [1] Current DVT Prophylaxis Guidelines with Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH) Are Inadequate for MICU Patients by Anti-Xa Levels
    Velasquez, A.
    Patel, H.
    Shaz, D.
    Perez, R. L.
    Leeper, K. V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [2] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    THROMBOSIS RESEARCH, 1997, 85 (03) : 259 - 265
  • [3] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (Enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1172 - P1172
  • [4] Anti-Xa monitoring is required in pregnant women on low molecular weight heparin (LMWH)
    Simpson, V. M. A.
    Pescott, M.
    Peebles, D.
    Cohen, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1060 - 1060
  • [5] Low-molecular weight heparin (LMWH) in pregnancy: Role of anti-Xa monitoring
    Abu-Hajir, M
    Kuhlmann, RS
    Wigton, TR
    Friedman, KD
    THROMBOSIS AND HAEMOSTASIS, 1999, : 846 - 846
  • [6] COMPARISON OF LOW-MOLECULAR WEIGHT HEPARIN (LMWH) AND UNFRACTIONATED HEPARIN (UFH) ON ACTIVATION OF HUMAN-PLATELETS INVITRO
    SCULLY, MF
    WESTWICK, J
    POLL, C
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 95 - 95
  • [7] BIOLOGICAL STUDY WITH LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND UNFRACTIONATED HEPARIN (UFH) IN CHRONIC-HEMODIALYSIS (HD)
    SIGUENZA, F
    GRAU, E
    CARIDAD, A
    MADUELL, F
    NERBON, J
    LINARES, M
    KIDNEY INTERNATIONAL, 1991, 40 (02) : 357 - 357
  • [8] INCREASED ANTI-XA BIOAVAILABILITY FOR A LOW-MOLECULAR WEIGHT HEPARIN (PK-10169) COMPARED WITH UNFRACTIONATED HEPARIN
    BARA, L
    BILLAUD, E
    KHER, A
    SAMAMA, M
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (03): : 316 - 317
  • [9] Is monitoring anti-Xa levels necessary in pregnant women on therapeutic low molecular weight heparin (LMWH)?
    Temming, Lorene A.
    Young, Omar M.
    Stout, Molly J.
    Tuuli, Methodius G.
    Macones, George A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S157 - S158
  • [10] Evaluation of the Hepcon HMS vs low-molecular-weight heparin (LMWH) anti-Xa activity
    Mertzlufft, F
    Hansen, R
    Kuppe, H
    Koster, A
    BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 : 78 - 78
12345